Evidence map›Paper›PMID 42198362›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Disproportionality Analysis and Timing of Drug-Associated Guillain-Barré Syndrome Onset Based on the Japanese Adverse Drug Event Report Database.

Shinya Toriumi, Yousuke Kurihara, Komei Shimokawa, Arihito Tanaka, Norito Araki, Osamu Kawai, Yasoo Sugiura, Yoshihiro Uesawa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shinya ToriumiDepartment of Medical Molecular Informatics, Meiji Pharmaceutical University, Kiyose 204-8588, Tokyo, Japan.ORCID 0000-0001-5521-0820
Yousuke KuriharaDepartment of Pharmacy, National Hospital Organization Kanagawa Hospital, Hadano 257-8585, Kanagawa, Japan.
Komei ShimokawaDepartment of Pharmacy, National Hospital Organization Kanagawa Hospital, Hadano 257-8585, Kanagawa, Japan.
Arihito TanakaDepartment of Respiratory Medicine, National Hospital Organization Kanagawa Hospital, Hadano 257-8585, Kanagawa, Japan.
Norito ArakiDepartment of Respiratory Medicine, National Hospital Organization Kanagawa Hospital, Hadano 257-8585, Kanagawa, Japan.
Osamu KawaiDepartment of Respiratory Medicine, National Hospital Organization Kanagawa Hospital, Hadano 257-8585, Kanagawa, Japan.
Yasoo SugiuraDepartment of General Thoracic Surgery, National Hospital Organization Saitama Hospital, Wako 351-0102, Saitama, Japan.ORCID 0000-0003-3534-1799
Yoshihiro UesawaDepartment of Medical Molecular Informatics, Meiji Pharmaceutical University, Kiyose 204-8588, Tokyo, Japan.ORCID 0000-0002-5773-991X

Funding

Japan Society for the Promotion of Science 22K06707.
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acute inflammatory demyelinating polyneuropathydisproportionality analysisGuillain–Barré syndromeimmune checkpoint inhibitorsJapanese adverse drug event report databasepharmacovigilancespontaneous reporting systemtime-to-onset analysisvaccinesWeibull distribution

Identifiers

PMID42198362
PMCPMC13209910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.